S&P 500   5,011.12
DOW   37,775.38
QQQ   423.41
What's Driving Tesla Lower Ahead of its Earnings?
Stock market today: Asian markets sink, with Japan’s Nikkei down 3.5%, as Mideast tensions flare
How major US stock indexes fared Thursday, 4/18/2024
3 Steel Stocks Could Soar on New China Tariffs
CSX Co.: The Railroad Powering Ahead with an Earnings Beat
These are the Top 4 Stocks for Buybacks in 2024
'There is no time to waste': EU leaders want to boost competitiveness to close gap with US and China
S&P 500   5,011.12
DOW   37,775.38
QQQ   423.41
What's Driving Tesla Lower Ahead of its Earnings?
Stock market today: Asian markets sink, with Japan’s Nikkei down 3.5%, as Mideast tensions flare
How major US stock indexes fared Thursday, 4/18/2024
3 Steel Stocks Could Soar on New China Tariffs
CSX Co.: The Railroad Powering Ahead with an Earnings Beat
These are the Top 4 Stocks for Buybacks in 2024
'There is no time to waste': EU leaders want to boost competitiveness to close gap with US and China
S&P 500   5,011.12
DOW   37,775.38
QQQ   423.41
What's Driving Tesla Lower Ahead of its Earnings?
Stock market today: Asian markets sink, with Japan’s Nikkei down 3.5%, as Mideast tensions flare
How major US stock indexes fared Thursday, 4/18/2024
3 Steel Stocks Could Soar on New China Tariffs
CSX Co.: The Railroad Powering Ahead with an Earnings Beat
These are the Top 4 Stocks for Buybacks in 2024
'There is no time to waste': EU leaders want to boost competitiveness to close gap with US and China
S&P 500   5,011.12
DOW   37,775.38
QQQ   423.41
What's Driving Tesla Lower Ahead of its Earnings?
Stock market today: Asian markets sink, with Japan’s Nikkei down 3.5%, as Mideast tensions flare
How major US stock indexes fared Thursday, 4/18/2024
3 Steel Stocks Could Soar on New China Tariffs
CSX Co.: The Railroad Powering Ahead with an Earnings Beat
These are the Top 4 Stocks for Buybacks in 2024
'There is no time to waste': EU leaders want to boost competitiveness to close gap with US and China

Castle Biosciences (CSTL) SEC Filings & 10K Form

$19.20
+0.36 (+1.91%)
(As of 04/18/2024 ET)

Recent Castle Biosciences SEC Filings

DateFilerForm TypeView
04/16/2024
11:15 PM
Castle Biosciences (Filer)
Form EFFECT
04/16/2024
3:46 PM
Castle Biosciences (Issuer)
MAETZOLD DEREK J (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
04/12/2024
3:36 PM
Castle Biosciences (Subject)
MAETZOLD DEREK J (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
04/10/2024
3:35 PM
BRADBURY DANIEL (Reporting)
Castle Biosciences (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
04/10/2024
3:05 PM
Castle Biosciences (Filer)
Form DEF 14A
04/10/2024
3:07 PM
Castle Biosciences (Filer)
Form DEFA14A
04/10/2024
3:08 PM
Castle Biosciences (Filer)
Form ARS
04/08/2024
3:31 PM
BRADBURY DANIEL (Reporting)
Castle Biosciences (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
04/05/2024
3:37 PM
Castle Biosciences (Issuer)
MAETZOLD DEREK J (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
04/04/2024
4:02 PM
BRADBURY DANIEL (Reporting)
Castle Biosciences (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
03/28/2024
3:43 PM
Castle Biosciences (Issuer)
Cotton Rodney (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/28/2024
3:30 PM
Castle Biosciences (Issuer)
Cotton Rodney (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
03/22/2024
4:16 PM
Castle Biosciences (Issuer)
MAETZOLD DEREK J (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/11/2024
4:18 PM
Castle Biosciences (Issuer)
MAETZOLD DEREK J (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/07/2024
4:14 PM
Castle Biosciences (Subject)
MAETZOLD DEREK J (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
03/06/2024
4:58 PM
Castle Biosciences (Issuer)
MAETZOLD DEREK J (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/06/2024
5:00 PM
Castle Biosciences (Issuer)
Stokes Frank (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/06/2024
5:04 PM
Castle Biosciences (Issuer)
Oelschlager Kristen M (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/06/2024
5:07 PM
Castle Biosciences (Issuer)
Juvenal Tobin W (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/06/2024
4:52 PM
BRADBURY DANIEL (Reporting)
Castle Biosciences (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/05/2024
6:14 PM
Castle Biosciences (Subject)
MAETZOLD DEREK J (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
02/28/2024
4:08 PM
Castle Biosciences (Filer)
Form S-3
Registration statement under Securities Act of 1933  
02/28/2024
4:15 PM
Castle Biosciences (Filer)
Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans  
02/09/2024
3:49 PM
BRADBURY DANIEL (Reporting)
Castle Biosciences (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/09/2024
11:43 AM
Castle Biosciences (Subject)
WASATCH ADVISORS LP (Filed by)
Form SC 13G/A
02/07/2024
3:19 PM
BRADBURY DANIEL (Reporting)
Castle Biosciences (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/08/2024
3:19 PM
BRADBURY DANIEL (Reporting)
Castle Biosciences (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/08/2024
6:04 AM
Castle Biosciences (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/04/2024
4:16 PM
Castle Biosciences (Issuer)
Juvenal Tobin W (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/27/2023
3:18 PM
Castle Biosciences (Issuer)
MAETZOLD DEREK J (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/22/2023
3:06 PM
Castle Biosciences (Issuer)
MAETZOLD DEREK J (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/20/2023
3:46 PM
Castle Biosciences (Issuer)
MAETZOLD DEREK J (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/14/2023
4:32 PM
BRADBURY DANIEL (Reporting)
Castle Biosciences (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
12/14/2023
4:39 PM
Castle Biosciences (Issuer)
MAETZOLD DEREK J (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/13/2023
5:24 PM
Castle Biosciences (Subject)
MAETZOLD DEREK J (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
12/12/2023
6:39 PM
Castle Biosciences (Issuer)
Oelschlager Kristen M (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/12/2023
6:28 PM
Castle Biosciences (Issuer)
Juvenal Tobin W (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/12/2023
6:33 PM
Castle Biosciences (Issuer)
Stokes Frank (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/12/2023
6:19 PM
BRADBURY DANIEL (Reporting)
Castle Biosciences (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
12/12/2023
6:23 PM
Castle Biosciences (Issuer)
MAETZOLD DEREK J (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/08/2023
3:35 PM
BRADBURY DANIEL (Reporting)
Castle Biosciences (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
Explore the Future: Unlock the Top 3 AI Stocks for 2024 Report (Ad)

Eager to enhance your investment strategies with foresight? Dive into our intriguing report: "The Top 3 AI Stocks for 2024." Gain profound insights and uncover the secrets with just a click! Why This Report Is Your Gateway to Success: * Expertly Curated: Delve into the AI stocks handpicked by our market analysts for 2024's success story. * In-Depth Analysis: Dive deep into comprehensive profiles and explore each top stock. (**By clicking the link you are subscribing to The Wealthiest Investor Newsletter and may receive up to 2 additional free bonus subscriptions. Unsubscribing is easy. Full disclosures found here.)

[Get Your Insights Now]
12/08/2023
3:38 PM
Castle Biosciences (Issuer)
MAETZOLD DEREK J (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/05/2023
4:46 PM
BRADBURY DANIEL (Reporting)
Castle Biosciences (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
12/05/2023
4:49 PM
Castle Biosciences (Issuer)
MAETZOLD DEREK J (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/04/2023
3:50 PM
Castle Biosciences (Filer)
Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans  
12/01/2023
3:43 PM
BRADBURY DANIEL (Reporting)
Castle Biosciences (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
12/01/2023
3:30 PM
BRADBURY DANIEL (Reporting)
Castle Biosciences (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
12/01/2023
3:34 PM
Castle Biosciences (Issuer)
MAETZOLD DEREK J (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
11/22/2023
3:37 PM
Castle Biosciences (Subject)
MAETZOLD DEREK J (Reporting)
Form 144/A
11/22/2023
3:22 PM
BRADBURY DANIEL (Reporting)
Castle Biosciences (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
11/22/2023
3:20 PM
Castle Biosciences (Issuer)
MAETZOLD DEREK J (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
11/09/2023
4:25 PM
Castle Biosciences (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/02/2023
3:14 PM
Castle Biosciences (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
09/06/2023
3:40 PM
Castle Biosciences (Issuer)
MAETZOLD DEREK J (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
09/01/2023
3:23 PM
BRADBURY DANIEL (Reporting)
Castle Biosciences (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
09/01/2023
3:26 PM
Castle Biosciences (Issuer)
MAETZOLD DEREK J (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
07/18/2023
3:51 PM
Castle Biosciences (Issuer)
Castle Biosciences (Issuer)
Goldberg Ellen (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
07/18/2023
3:41 PM
Caple Kim (Reporting)
Castle Biosciences (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
07/11/2023
4:06 PM
BRADBURY DANIEL (Reporting)
Castle Biosciences (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
07/11/2023
4:10 PM
Castle Biosciences (Issuer)
MAETZOLD DEREK J (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/06/2023
3:48 PM
Castle Biosciences (Issuer)
Goldberg Ellen (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/06/2023
3:35 PM
Castle Biosciences (Issuer)
Harrison Miles (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/06/2023
3:38 PM
Castle Biosciences (Issuer)
Goldberg Ellen (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/06/2023
3:40 PM
Castle Biosciences (Issuer)
Cole G Bradley (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/06/2023
3:42 PM
Aspinall Mara G. (Reporting)
Castle Biosciences (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/06/2023
3:44 PM
BRADBURY DANIEL (Reporting)
Castle Biosciences (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/06/2023
3:46 PM
Caple Kim (Reporting)
Castle Biosciences (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/06/2023
3:33 PM
Castle Biosciences (Issuer)
Olson Tiffany (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/05/2023
5:02 AM
Castle Biosciences (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/01/2023
3:16 PM
Castle Biosciences (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/30/2023
4:55 PM
Castle Biosciences (Issuer)
Harrison Miles (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/30/2023
4:57 PM
Castle Biosciences (Issuer)
Olson Tiffany (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/30/2023
4:38 PM
Aspinall Mara G. (Reporting)
Castle Biosciences (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/30/2023
4:42 PM
BRADBURY DANIEL (Reporting)
Castle Biosciences (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/30/2023
4:45 PM
Caple Kim (Reporting)
Castle Biosciences (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/30/2023
4:48 PM
Castle Biosciences (Issuer)
Cole G Bradley (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/30/2023
4:52 PM
Castle Biosciences (Issuer)
Goldberg Ellen (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/15/2023
12:43 PM
Castle Biosciences (Filer)
Form DEFA14A
05/08/2023
3:21 PM
Castle Biosciences (Issuer)
MAETZOLD DEREK J (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/08/2023
3:26 PM
BRADBURY DANIEL (Reporting)
Castle Biosciences (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/04/2023
4:19 PM
BRADBURY DANIEL (Reporting)
Castle Biosciences (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
(Data available from 1/1/2016 forward)


Related Companies and Tools

This page (NASDAQ:CSTL) was last updated on 4/18/2024 by MarketBeat.com Staff

From Our Partners